評估胸水（PF）N末端B型利鈉肽原（NTproBNP）水平在識別心衰竭（HF）相關胸腔積液（PE）中的鑑別特性。
適應症：Pleural Effusion、Heart Failure、Malignant Neoplasm、Fluid Overload、Hypoalbuminemia、Renal Failure、Cirrhosis、Infections
收案條件
納入條件
- Patients hospitalized for heart failure and pleural effusion
- Pleural tapping indicated for pleural fluid analysis.
- Aged 18 years old or above
排除條件
- History of intrapleural therapy (including talc and fibrinolytic) in the ipsilateral pleural space.
- History of surgical decortication or pleurodesis in the ipsilateral pleural space.
- Ipsilateral thoracic or cardiac surgery in the past 3 months.
- Failure to obtain informed consent due to the patient's refusal or cognitive impairment.
收案條件維持 ClinicalTrials.gov 原始英文登錄資料，實際收案資格以研究團隊的正式評估與受試者同意書為準。資料來源：ClinicalTrials.gov，每兩週自動更新，最後同步：2026年10月8日。